Caitlin Wetzler
About Caitlin Wetzler
Caitlin Wetzler is the Associate Director of Study Optimization at Bristol Myers Squibb in the New York City Metropolitan Area.
Associate Director at Bristol Myers Squibb
Caitlin Wetzler currently holds the position of Associate Director, Study Optimization at Bristol Myers Squibb in the New York City Metropolitan Area. In this role, she is responsible for evaluating clinical trial protocols, focusing on both cost drivers and business outcomes. Caitlin also facilitates discussions with stakeholders to address scientific, regulatory, and operational trade-offs in clinical trial design.
Career at Celgene
From 2017 to 2020, Caitlin Wetzler worked at Celgene in Montvale, New Jersey as Manager of Portfolio Sourcing & Relationship Management. During her tenure, she was involved in managing relationships and sourcing for various portfolios, enhancing the efficiency and effectiveness of clinical operations.
Clinical Operations at Ferring Pharmaceuticals
Between 2013 and 2017, Caitlin served in the Clinical Operations department at Ferring Pharmaceuticals. Her 4-year tenure contributed to the optimization of clinical trials, improving patient and site experiences. This role helped solidify her expertise in optimizing clinical study protocols and enhancing trial outcomes.
Educational Background at Rutgers University
Caitlin Wetzler completed her Bachelor of Arts at Rutgers University, focusing on Psychology and Behavioral Pharmacology. Her academic background laid the foundation for her career in clinical research, providing her with essential skills and knowledge in both quantitative and qualitative analysis of clinical trial impacts.
Experience at PsychoGenics
From 2009 to 2013, Caitlin Wetzler worked as a Senior Research Associate at PsychoGenics in Montvale, New Jersey. Her role involved substantial research responsibilities, contributing to the organization's clinical research capabilities over her 4-year tenure.